Impact of patients’ refusal to undergo adjuvant treatment measures on survival

• Conditions: C50.9; Breast, unspecified

• Registration Number: DRKS00021820
• Lead Sponsor: Ortenau-Klinikum Offenburg-Kehl

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Completion: 2020-05-21
• Study Start: 2020-05-27
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 4315

Inclusion Criteria

Patients with primary diagnosis of breast cancer who were treated at the Ortenau-Klinikum Offenburg-Kehl Breast Center between 1/1997 and 12/2019.

Exclusion Criteria

Non primary cases, e.g. through treatment in another hospital. Primary palliative cases.

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Presentation of survival data and recurrence-free survival depending on the acceptance or rejection of the tumor board recommendation.

Secondary Outcome Measures

Name	Time	Method
Patient and / or disease characteristics associated with rejection of the tumor board recommendation.